Rocuronium-induced neuromuscular block and reversibility with sugammadex at the corrugator supercilii and adductor pollicis muscles
Not Applicable
- Conditions
- Surgical patients requiring general anesthesia
- Registration Number
- JPRN-UMIN000010240
- Lead Sponsor
- ihon University of Medicine Department of Anesthesiology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
1)Patients having allergic factors to neuromuscular blocking agents 2) ASA risk 4 and above 3) BMI 30 and above or below 18.5 4)Patients having hepatic and renal disorders
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Optimum dose of sugammadex for the reversal of neuromuscular blockade at the corrugator supercilii muscle.
- Secondary Outcome Measures
Name Time Method